Total Payments
$11,432
2024 Payments
$395.40
Companies
8
Transactions
16
Medicare Patients
6,669
Medicare Billing
$300,353
Payment Breakdown by Category
Consulting$9,140 (80.0%)
Food & Beverage$1,897 (16.6%)
Travel$394.63 (3.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,140 | 7 | 80.0% |
| Food and Beverage | $1,897 | 7 | 16.6% |
| Travel and Lodging | $394.63 | 2 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $7,140 | 2 | $0 (2020) |
| Terumo Medical Corporation | $2,000 | 5 | $0 (2021) |
| Ironwood Pharmaceuticals, Inc | $1,315 | 2 | $0 (2017) |
| BioCardia, Inc. | $376.04 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $299.99 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $124.90 | 1 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $95.41 | 1 | $0 (2024) |
| GE HealthCare | $80.84 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $395.40 | 3 | Janssen Pharmaceuticals, Inc ($299.99) |
| 2023 | $80.84 | 1 | GE HealthCare ($80.84) |
| 2021 | $2,000 | 5 | Terumo Medical Corporation ($2,000) |
| 2020 | $7,140 | 2 | Amgen Inc. ($7,140) |
| 2018 | $310.53 | 2 | BioCardia, Inc. ($185.63) |
| 2017 | $1,505 | 3 | Ironwood Pharmaceuticals, Inc ($1,315) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $95.41 | General |
| Category: Neurology | ||||||
| 10/10/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Neuroscience | ||||||
| 03/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: Neuroscience | ||||||
| 02/02/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $80.84 | General |
| 10/20/2021 | Terumo Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 09/10/2021 | Terumo Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 06/10/2021 | Terumo Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 05/10/2021 | Terumo Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 01/25/2021 | Terumo Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 07/22/2020 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $3,570.00 | General |
| 07/22/2020 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $3,570.00 | General |
| 10/30/2018 | BioCardia, Inc. | CardiAMP (Biological) | Travel and Lodging | Cash or cash equivalent | $185.63 | General |
| Category: heart failure | ||||||
| 06/01/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/07/2017 | Ironwood Pharmaceuticals, Inc | IW-1973 | Food and Beverage | In-kind items and services | $1,105.60 | General |
| 12/07/2017 | Ironwood Pharmaceuticals, Inc | IW-1973 | Travel and Lodging | In-kind items and services | $209.00 | General |
| 11/12/2017 | BioCardia, Inc. | CardiAMP System (Device) | Food and Beverage | Cash or cash equivalent | $190.41 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,783 | 1,895 | $672,256 | $72,556 |
| 2022 | 14 | 1,970 | 2,092 | $650,584 | $82,239 |
| 2021 | 12 | 1,503 | 1,560 | $579,467 | $76,092 |
| 2020 | 14 | 1,413 | 1,472 | $483,722 | $69,465 |
Total Patients
6,669
Total Services
7,019
Medicare Billing
$300,353
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 627 | 648 | $370,413 | $35,177 | 9.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 89 | 90 | $64,026 | $12,108 | 18.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 54 | 68 | $18,252 | $5,700 | 31.2% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 78 | 78 | $45,234 | $4,150 | 9.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 330 | 397 | $24,217 | $2,958 | 12.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 124 | 127 | $46,445 | $2,708 | 5.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $25,753 | $1,664 | 6.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 28 | 28 | $4,308 | $1,540 | 35.8% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 26 | 26 | $9,832 | $1,421 | 14.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 80 | 80 | $13,200 | $1,357 | 10.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 69 | 69 | $13,223 | $748.20 | 5.7% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 45 | 45 | $8,622 | $673.63 | 7.8% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 102 | 105 | $8,784 | $637.98 | 7.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 24 | 26 | $7,306 | $622.18 | 8.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 12 | $2,926 | $578.15 | 19.8% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Office | 2023 | 26 | 26 | $2,624 | $371.79 | 14.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 53 | 53 | $7,091 | $140.14 | 2.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 710 | 736 | $371,624 | $42,359 | 11.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 102 | 102 | $51,450 | $10,542 | 20.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 52 | 61 | $11,452 | $5,029 | 43.9% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2022 | 82 | 82 | $38,515 | $4,788 | 12.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 127 | 131 | $39,079 | $2,919 | 7.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 325 | 377 | $22,997 | $2,829 | 12.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 38 | 45 | $5,661 | $2,472 | 43.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 36 | $8,940 | $2,297 | 25.7% |
About Dr. Phillip Yang, MD
Dr. Phillip Yang, MD is a Cardiovascular Disease healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1932249174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Phillip Yang, MD has received a total of $11,432 in payments from pharmaceutical and medical device companies, with $395.40 received in 2024. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($9,140).
As a Medicare-enrolled provider, Yang has provided services to 6,669 Medicare beneficiaries, totaling 7,019 services with total Medicare billing of $300,353. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Stanford, CA
- Active Since 02/07/2007
- Last Updated 04/27/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1932249174
Products in Payments
- IW-1973 $1,315
- INVEGA (Drug) $299.99
- CardiAMP System (Device) $190.41
- CardiAMP (Biological) $185.63
- BRILINTA (Drug) $124.90
- UZEDY (Drug) $95.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Stanford
Dr. Wilber Su, Md, MD
Cardiovascular Disease — Payments: $1.1M
Cardiovascular Disease $1.1M
Kenneth Mahaffey, Md, MD
Cardiovascular Disease — Payments: $787,234
Cardiovascular Disease $787,234
Dr. Todd Brinton, M.d, M.D
Cardiovascular Disease — Payments: $632,155
Cardiovascular Disease $632,155
Peter Fitzgerald, Md, MD
Cardiovascular Disease — Payments: $305,461
Cardiovascular Disease $305,461
David Lee, Md, MD
Cardiovascular Disease — Payments: $286,441
Cardiovascular Disease $286,441
Jeffrey Teuteberg, Md, MD
Cardiovascular Disease — Payments: $240,818
Cardiovascular Disease $240,818